Your browser doesn't support javascript.
loading
First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report.
Hoff, Camilla O; Dal Lago, Eduardo Andreazza; Siqueira, Juliana Mota; de Sousa, Luana G; El-Naggar, Adel K; Ahnert, Jordi Rodon; Ferrarotto, Renata.
Afiliação
  • Hoff CO; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dal Lago EA; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Siqueira JM; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • de Sousa LG; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • El-Naggar AK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ahnert JR; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
JCO Precis Oncol ; 8: e2300633, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38579194
ABSTRACT
First use of AXL-targeting in adenoid cystic carcinoma (ACC); with positive results, ACC now included in AXL studies.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Adenoide Cístico / Receptor Tirosina Quinase Axl Limite: Humans Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Adenoide Cístico / Receptor Tirosina Quinase Axl Limite: Humans Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2024 Tipo de documento: Article